Hypertension

• FDA approval · 2007-02-02
  FDA Approved: LOTENSIN — Supplemental Application (Validus Pharmaceuticals LLC)

  FDA approves a supplemental application for Lotensin (benazepril hydrochloride) submitted by Validus Pharmaceuticals LLC.

• FDA approval · 2007-02-02
  FDA Approved: BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Padagis US LLC)

  FDA approved a supplemental application for Benazepril hydrochloride and hydrochlorothiazide (Padagis US LLC), updating the product labeling…

• FDA approval · 2007-01-30
  FDA Approved: LISINOPRIL — Supplemental Application (Quallent Pharmaceuticals Health LLC)

  The FDA approved a supplemental application for lisinopril filed by Quallent Pharmaceuticals Health LLC.

• FDA approval · 2007-01-27
  FDA Approved: ATENOLOL — Supplemental Application (Zydus Lifesciences Limited)

  FDA approved a supplemental application for Atenolol submitted by Zydus Lifesciences Limited.

• FDA approval · 2007-01-11
  FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

  FDA approved a supplemental application for Lisinopril and Hydrochlorothiazide from Lupin Pharmaceuticals, Inc. under the supplemental appro…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2007-01-10
  FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Actavis Pharma, Inc.)

  The FDA approved a supplemental application for the generic lisinopril and hydrochlorothiazide combination from Actavis Pharma, Inc.

• FDA approval · 2007-01-03
  FDA Approved: INDERAL LA — Supplemental Application (ANI Pharmaceuticals, Inc.)

  The FDA approved a supplemental application for INDERAL LA (propranolol hydrochloride) submitted by ANI Pharmaceuticals, Inc. This action au…

• FDA approval · 2006-12-27
  FDA Approved: BISOPROLOL FUMARATE — Original Application (NorthStar Rx LLC)

  FDA approved the original ANDA for Bisoprolol Fumarate tablets from NorthStar Rx LLC, making a generic beta-blocker available for the treatm…

• FDA approval · 2006-12-27
  FDA Approved: ATENOLOL — Original Application (Ipca Laboratories Limited)

  FDA approved the original ANDA for Atenolol by Ipca Laboratories Limited, authorizing a generic atenolol product. Atenolol is used for condi…

• FDA approval · 2006-12-21
  FDA Approved: HYZAAR — Supplemental Application (Organon LLC)

  The FDA approved a supplemental application for HYZAAR (losartan potassium and hydrochlorothiazide) from Organon LLC.

• FDA approval · 2006-12-15
  FDA Approved: DOXAZOSIN — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  FDA approved a supplemental application for doxazosin mesylate (DOXAZOSIN) submitted by Teva Pharmaceuticals USA, Inc.

• FDA approval · 2006-12-04
  FDA Approved: CARTIA XT — Supplemental Application (Actavis Pharma, Inc.)

  FDA approved a supplemental application for CARTIA XT (diltiazem hydrochloride) submitted by Actavis Pharma, Inc., authorizing changes to th…

• FDA approval · 2006-11-30
  FDA Approved: MOEXIPRIL HYDROCHLORIDE — Original Application (Chartwell RX, LLC)

  FDA approved the original application for Moexipril hydrochloride as a generic product by Chartwell RX, LLC for the treatment of hypertensio…

• FDA approval · 2006-10-20
  FDA Approved: COREG CR — Original Application (Waylis Therapeutics LLC)

  FDA approved COREG CR, an extended-release formulation of carvedilol phosphate, under an original NDA from Waylis Therapeutics LLC.

• FDA approval · 2006-09-27
  FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Original Application (Lupin Pharmaceuticals, Inc.)

  FDA approved Lupin's lisinopril and hydrochlorothiazide as a generic fixed-dose combination for the treatment of hypertension.

• FDA approval · 2006-09-18
  FDA Approved: FUROSEMIDE — Original Application (Ipca Laboratories Limited)

  FDA approved the Original Application for furosemide from Ipca Laboratories Limited, enabling a generic version of the diuretic to be market…

• FDA approval · 2006-09-13
  FDA Approved: ATENOLOL — Original Application (Rising Pharma Holdings, Inc.)

  FDA approved Atenolol as a generic under ANDA077443 from Rising Pharma Holdings, Inc. for the treatment of hypertension, angina pectoris, an…

• FDA approval · 2006-08-29
  FDA Approved: HYZAAR — Supplemental Application (Organon LLC)

  FDA approved a supplemental application for HYZAAR (losartan potassium and hydrochlorothiazide) submitted by Organon LLC.

• FDA approval · 2006-08-28
  FDA Approved: COREG — Supplemental Application (Waylis Therapeutics LLC)

  The FDA approved a supplemental application for Coreg (carvedilol) submitted by Waylis Therapeutics LLC.

• FDA approval · 2006-08-17
  FDA Approved: CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)

  The FDA approved ANI Pharmaceuticals' supplemental application for candesartan cilexetil and hydrochlorothiazide, authorizing a fixed-dose c…

• FDA approval · 2006-08-17
  FDA Approved: ATACAND — Supplemental Application (ANI Pharmaceuticals, Inc.)

  FDA approved a supplemental application for ATACAND (candesartan cilexetil) submitted by ANI Pharmaceuticals, Inc., to modify or expand the …

• FDA approval · 2006-08-14
  FDA Approved: CAPTOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Rising Pharma Holdings, Inc.)

  FDA approved a supplemental application for CAPTOPRIL AND HYDROCHLOROTHIAZIDE from Rising Pharma Holdings, Inc., to support its ongoing use …

• FDA approval · 2006-08-08
  FDA Approved: LISINOPRIL — Supplemental Application (Quallent Pharmaceuticals Health LLC)

  FDA approved a supplemental application for lisinopril from Quallent Pharmaceuticals Health LLC.

• FDA approval · 2006-07-27
  FDA Approved: TOPROL XL — Supplemental Application (Melinta Therapeutics, LLC)

  The FDA approved a supplemental application for TOPROL XL (metoprolol succinate) from Melinta Therapeutics, LLC. The approval updates the pr…

• FDA approval · 2006-07-17
  FDA Approved: ATENOLOL — Supplemental Application (Zydus Lifesciences Limited)

  The FDA approved a supplemental application for Atenolol filed by Zydus Lifesciences Limited (ANDA 076900).